Market Overview:
The Global Home Infusion Therapy Market size is expected to grow from USD 21.57 billion in 2022 to USD 35.78 billion by 2030, at a CAGR of 6.53% during the forecast period (2023-2030).
Home infusion therapy refers to the administration of drugs or biologicals intravenously or subcutaneously to a patient. For home infusion, need the medication (antivirals, immune globulin), machinery (pump), and supplies (tubing and catheters). Home infusion therapy can be used in place of oral medication. Nurses frequently visit the infusion site to monitor the infusion site and change the dressing as well as instruct patients or caregivers on how to self-administer the medication and inform them of side effects and therapeutic goals. To ensure that the home infusion procedure is successful, patients, doctors, hospital discharge planners, health plans, home infusion pharmacies, and, if necessary, home health organizations must all collaborate.
Top Key Players in the Home Infusion Therapy Market:
CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd., and Other Major Players.
Market Dynamics and Factors for Home Infusion Therapy Market:
Drivers:
Hospital-Like Care at Home
When patients choose home infusion services, they can get a cutting-edge and comprehensive package of services with a range of care options. By providing care in the convenience of their own homes, home services can assist patients in avoiding lengthy hospital stays and high medical costs. As part of several infusion therapies, people can receive IV infusions in a cozy and secure setting. A patient recovering from surgery or undergoing surgery therapy can access a range of home care infusion services with the help of a reliable healthcare professional. From the initial client interaction to delivering expert home therapy, professionals can help patients with all kinds of infusions.
Opportunities:
Increasing Geriatric Population
By 2025, the world's population will increase by one billion, with about a third of those being 65 or older as life expectancy increases. Urbanization and middle-class comforts are both growing, which may contribute to more sedentary lifestyles and chronic illnesses. There are worries that all of this will put additional pressure on the ability of the global health system to provide and pay for care. As a result, there has been a sizable shift in healthcare toward a more community-based, patient-centered strategy. The market for home infusion therapy has expanded due to regulations in the medical field.
Segmentation Analysis of the Home Infusion Therapy Market:
By product type, the infusion pump segment is expected to dominate the market. Infusion pumps have numerous benefits over manual fluid administration, including the ability to give fluids in very small quantities and at precisely programmed rates or automatic intervals.
By Application, anti-infective is likely to dominate in this area. One of the most regularly prescribed home infusion therapies is anti-infective therapy (antibiotics, antifungals, and antivirals), which can be safely managed at home.
Regional Analysis of the Home Infusion Therapy Market:
North America is expected to dominate the market during the forecast period. The main drivers of the market's growth are the rising incidence of chronic diseases and the mounting strain on the infrastructure of primary healthcare. In this area, it's common to have neurological disorders, rheumatoid arthritis, hemophilia, immune system deficiencies, and multiple sclerosis. The number of patients served by home infusion and specialty providers in the United States in 2019 was over 3 million, up 300 percent from the previous industry study in 2008.
Key Industry Development:
In December 2021, the acquisition of Hillrom by Baxter International Inc. has been completed. This acquisition will aid the company in expanding its geographic reach and integrating medical device technologies to improve patient care, reduce costs, and streamline operations.
In November 2021, Eitan Medical was appointed to the NHIA's Future of Infusion Advisory Council (FIAC). The FIAC is a strategic advisory organization made up of manufacturers and service providers with a presence in the home and alternate site infusion industry.
Regional Outlook (Revenue in USD Million; Volume in Units, 2023-2030)
North America
- The U.S.
- Canada
- Mexico
Eastern Europe
- Russia
- Bulgaria
- The Czech Republic
- Hungary
- Poland
- Romania
- Rest of Eastern Europe
Western Europe
- Germany
- UK
- France
- Netherlands
- Italy
- Spain
- Rest of Western Europe
Asia Pacific
- China
- India
- Japan
- Singapore
- Australia
- New-Zealand
- Rest of APAC
Middle East & Africa
- Turkey
- Saudi Arabia
- Qatar
- UAE
- Israel
- South Africa
South America
- Brazil
- Argentina
- Rest of SA
